AQUACEL^® Ag+ Dressing Resources: See the Evidence

Download the full article or the clinical summary A multi-country evaluation¹ was recently published involving 113* cases of challenging at-risk or infected wounds with no formal inclusion or exclusion criteria (to reflect day-to-day practice) and continuation of the existing protocol of care except for replacement of the primary dressing with AQUACEL^® Ag+ Dressing.

In management periods averaging 4.1 weeks:

• 95% of wounds had either improved or healed completely¹
• 63% of all wounds achieved at least a 75% reduction in wound size¹, with an average reduction in wound size of 73% across all wounds¹

Further, applying these results to a published wound care costing method,² the investigators estimated a potential saving of approximately 30% in the cost of primary dressings when AQUACEL^® Ag+ dressing is used.¹ (Prices based on NHS Prices 2008/9, Drug Tariff November 2009 and BNF September 2009.)

Watch the video on how biofilm delays wound healing and how AQUACEL^® Ag+ dressings perform.